Cross-country comparisons of health-care costs: the case of cancer treatment in the Nordic countries.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Kalseth, JoridHalvorsen, Thomas
Kalseth, Birgitte
Sarheim Anthun, Kjartan
Peltola, Mikko
Kautiainen, Kirsi
Häkkinen, Unto
Medin, Emma
Lundgren, Jonatan
Rehnberg, Clas
Másdóttir, Birna Björg
Heimisdottir, Maria
Bjarnadóttir, Helga Hrefna
Køtlum, Jóanis Erik
Kilsmark, Janni
Halsteinli, Vidar
Issue Date
2014-04
Metadata
Show full item recordCitation
Health Policy 2014, 115 (2-3):172-9Abstract
The objective of this study is to perform a cross-country comparison of cancer treatment costs in the Nordic countries, and to demonstrate the added value of decomposing documented costs in interpreting national differences. The study is based on individual-level data from national patient and prescription drug registers, and data on cancer prevalence from the NORDCAN database. Hospital costs were estimated on the basis of information on diagnosis-related groups (DRG) cost weights and national unit costs. Differences in per capita costs were decomposed into two stages: stage one separated the price and volume components, and stage two decomposed the volume component, relating the level of activity to service needs and availability. Differences in the per capita costs of cancer treatment between the Nordic countries may be as much as 30 per cent. National differences in the costs of treatment mirror observed differences in total health care costs. Differences in health care costs between countries may relate to different sources of variation with different policy implications. Comparisons of per capita spending alone can be misleading if the purpose is to evaluate, for example, differences in service provision and utilisation. The decomposition analysis helps to identify the relative influence of differences in the prevalence of cancer, service utilisation and productivity.Description
To access publisher's full text version of this article click on the hyperlink at the bottom of the pageAdditional Links
http://dx.doi.org/10.1016/j.healthpol.2014.01.003Rights
Archived with thanks to Health policy (Amsterdam, Netherlands)ae974a485f413a2113503eed53cd6c53
10.1016/j.healthpol.2014.01.003
Scopus Count
Collections
Related articles
- NORDCAN--a Nordic tool for cancer information, planning, quality control and research.
- Authors: Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, Køtlum JE, Olafsdóttir E, Pukkala E, Storm HH
- Issue date: 2010 Jun
- Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results.
- Authors: Storm HH, Engholm G, Hakulinen T, Tryggvadóttir L, Klint A, Gislum M, Kejs AM, Bray F
- Issue date: 2010 Jun
- Trends in the overall survival of cancer patients diagnosed 1964-2003 in the Nordic countries followed up to the end of 2006: the importance of case-mix.
- Authors: Storm HH, Kejs AM, Engholm G, Tryggvadóttir L, Klint A, Bray F, Hakulinen T
- Issue date: 2010 Jun
- Trends in cancer survival in the Nordic countries 1990-2016: the NORDCAN survival studies.
- Authors: Lundberg FE, Andersson TM, Lambe M, Engholm G, Mørch LS, Johannesen TB, Virtanen A, Pettersson D, Ólafsdóttir EJ, Birgisson H, Johansson ALV, Lambert PC
- Issue date: 2020 Nov
- Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
- Authors: Tryggvadóttir L, Gislum M, Bray F, Klint A, Hakulinen T, Storm HH, Engholm G
- Issue date: 2010 Jun